| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |